Thompson Juliet — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Thompson Juliet has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Thompson Juliet

Juliet Thompson is a director of Indivior Pharmaceuticals Inc., a specialty pharmaceutical company focused on opioid use disorder treatment. According to the SEC filing dated 2026-01-28 (CIK 0001715258), Thompson held a director role with Indivior and reported zero purchases and zero sales in the filing period. Publicly available information in the SEC filing does not disclose additional details about her prior professional background.

RoleDirector
Notability25/100

Board memberships

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-14INDVIndivior Pharmaceuticals, Inc.A — Grant or award6.5K$0.00
2026-05-14INDVIndivior Pharmaceuticals, Inc.F — Tax withholding / forfeiture1.1K$38.28$43K
2026-01-28INDVIndivior Pharmaceuticals, Inc.A — Grant or award3.7K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Thompson Juliet?

Juliet Thompson is a director of Indivior Pharmaceuticals Inc., a specialty pharmaceutical company focused on opioid use disorder treatment. According to the SEC filing dated 2026-01-28 (CIK 0001715258), Thompson held a director role with Indivior and reported zero purchases and zero sales in the filing period. Publicly available information in the SEC filing does not disclose …

How many SEC Form 4 filings has Thompson Juliet submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Thompson Juliet's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Thompson Juliet profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.